Current Pain and Headache Reports

, 17:328

Cancer Pain Management: What’s New?

Cancer Pain (DA Marcus, Section Editor)

DOI: 10.1007/s11916-013-0328-9

Cite this article as:
Gaertner, J. & Schiessl, C. Curr Pain Headache Rep (2013) 17: 328. doi:10.1007/s11916-013-0328-9
Part of the following topical collections:
  1. Topical Collection on Cancer Pain


Decades after the publication of the World Health Organization’s analgesic ladder, cancer pain is still a major cause of suffering for patients with cancer and affects millions of people worldwide. Owing to the increasing incidence of cancer, cancer-related pain is a major public health problem worldwide. Unfortunately, current research revealed that available options for the successful treatment of cancer pain is still massively underutilized by physicians, and many patients suffer from insufficiently controlled pain despite available treatment options. This review aims to present a concise update about new data or treatment recommendations from the field of cancer pain management. Therefore, information from guidelines, systematic reviews, and original articles that were published in the year 2012 are presented. Specifically, the publication covers information on tapentadol, fixed oxycodone/naloxone combinations, rapid onset fentanyl, nabiximols, ketamine, denusomab, and specialized psychosocial interventions including early palliative care.


Cancer painTreatmentTapentadolRapid onset fentanylPsychosocial interventionsPalliative careFixed oxycodone/naloxone

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Palliative CareUniversity Hospital CologneCologneGermany
  2. 2.Center for Integrated OncologyUniversity HospitalCologne/BonnGermany
  3. 3.Clinical Trials Center Cologne BMBF 01KN0706CologneGermany